Drug Profile
Research programme: therapeutic antibodies - Takeda/UCSF
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Takeda; University of California at San Francisco
- Class Antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Undefined in USA (Parenteral)
- 21 Sep 2009 Early research in Undefined indication in USA (Parenteral)